论文部分内容阅读
幽门螺杆菌感染是近30年内发现的新发慢性传染性疾病。在我国,人群的感染水平非常高,平均为59%。幽门螺杆菌感染可导致上胃肠道疾病的发生,世界卫生组织已将幽门螺杆菌列入Ι类致癌因子。根除幽门螺杆菌可显著改善胃急、慢性炎症和萎缩,从而可能阻止致癌进程。因此,开展人群幽门螺杆菌感染的筛查并有效根除,进而减少上胃肠道疾病的危害是控制幽门螺杆菌感染的根本策略。对幽门螺杆菌感染问题的关注应当作重大社会公共卫生问题来对待,积极采取政府制订中长期控制规划;扩大筛查和根除的人群范围;将人群幽门螺杆菌筛查和根除纳入医保报销范围;加大宣传力度,提高群众认识;加大试剂疫苗研发力度等措施。
Helicobacter pylori infection is a newly acquired chronic infectious disease found in nearly 30 years. In our country, the level of infection in the population is very high, with an average of 59%. Helicobacter pylori infection can cause upper gastrointestinal diseases, the World Health Organization has included Helicobacter pylori class 1 carcinogen. The eradication of Helicobacter pylori can significantly improve the stomach, chronic inflammation and atrophy, which may prevent the carcinogenic process. Therefore, to carry out screening and effective eradication of Helicobacter pylori in human population, and then reduce the harm of upper gastrointestinal diseases is the fundamental strategy to control Helicobacter pylori infection. The concern about Helicobacter pylori infection should be treated as major social and public health problems and actively adopt the government’s formulation of medium and long term control plans; expand the scope of the population for screening and eradication; include the screening and eradication of Helicobacter pylori in the population within the scope of medical insurance reimbursement; Increase propaganda efforts to raise public awareness; increase reagent R & D efforts and other measures.